Biosino Bio-Technology and Science Inc
HKEX:8247
Intrinsic Value
Biosino Bio-Technology & Science, Inc. engages in the manufacture, sale, and distribution of in-vitro diagnostic reagent and pharmaceutical products. [ Read More ]
The intrinsic value of one Biosino Bio-Technology and Science Inc stock under the Base Case scenario is 2.55 HKD. Compared to the current market price of 0.9 HKD, Biosino Bio-Technology and Science Inc is Undervalued by 65%.
Valuation Backtest
Biosino Bio-Technology and Science Inc
Run backtest to discover the historical profit from buying and selling Biosino Bio-Technology and Science Inc stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Biosino Bio-Technology and Science Inc
| Current Assets | 350.1m |
| Cash & Short-Term Investments | 63.4m |
| Receivables | 179.8m |
| Other Current Assets | 106.9m |
| Non-Current Assets | 213.1m |
| Long-Term Investments | 99.2m |
| PP&E | 83.7m |
| Intangibles | 26.5m |
| Other Non-Current Assets | 3.7m |
| Current Liabilities | 320.7m |
| Accounts Payable | 111.5m |
| Other Current Liabilities | 209.2m |
| Non-Current Liabilities | 32.1m |
| Long-Term Debt | 5.5m |
| Other Non-Current Liabilities | 26.6m |
Earnings Waterfall
Biosino Bio-Technology and Science Inc
|
Revenue
|
289.1m
CNY
|
|
Cost of Revenue
|
-161.7m
CNY
|
|
Gross Profit
|
127.4m
CNY
|
|
Operating Expenses
|
-150.2m
CNY
|
|
Operating Income
|
-22.8m
CNY
|
|
Other Expenses
|
11.2m
CNY
|
|
Net Income
|
-11.6m
CNY
|
Free Cash Flow Analysis
Biosino Bio-Technology and Science Inc
Profitability Score
Profitability Due Diligence
Biosino Bio-Technology and Science Inc's profitability score is 39/100. The higher the profitability score, the more profitable the company is.
Score
Biosino Bio-Technology and Science Inc's profitability score is 39/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Biosino Bio-Technology and Science Inc's solvency score is 47/100. The higher the solvency score, the more solvent the company is.
Score
Biosino Bio-Technology and Science Inc's solvency score is 47/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Biosino Bio-Technology and Science Inc
Shareholder Return
Price
Biosino Bio-Technology and Science Inc
| Average Annual Return | 0.69% |
| Standard Deviation of Annual Returns | 31.26% |
| Max Drawdown | -78% |
| Market Capitalization | 130.2m HKD |
| Shares Outstanding | 144 707 180 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Biosino Bio-Technology & Science, Inc. engages in the manufacture, sale, and distribution of in-vitro diagnostic reagent and pharmaceutical products. The company is headquartered in Beijing, Beijing and currently employs 421 full-time employees. The company went IPO on 2006-02-27. The Company’s products include mono diagnostic reagent products and double diagnostic reagent products. Its products categories include liver diseases category, kidney diseases category, lipid diseases category, cardiovascular diseases category, glycometabolism category, inorganic ion category, pancreas diseases category and specific protein category. Its products are sold to hospitals and medical institutions.
Contact
IPO
Employees
Officers
The intrinsic value of one Biosino Bio-Technology and Science Inc stock under the Base Case scenario is 2.55 HKD.
Compared to the current market price of 0.9 HKD, Biosino Bio-Technology and Science Inc is Undervalued by 65%.
You don't have any saved screeners yet
